466 related articles for article (PubMed ID: 34323201)
21. Advances in AI for Protein Structure Prediction: Implications for Cancer Drug Discovery and Development.
Qiu X; Li H; Ver Steeg G; Godzik A
Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540759
[TBL] [Abstract][Full Text] [Related]
22. Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions.
Vatansever S; Schlessinger A; Wacker D; Kaniskan HÜ; Jin J; Zhou MM; Zhang B
Med Res Rev; 2021 May; 41(3):1427-1473. PubMed ID: 33295676
[TBL] [Abstract][Full Text] [Related]
23. Deep Learning for Drug Design: an Artificial Intelligence Paradigm for Drug Discovery in the Big Data Era.
Jing Y; Bian Y; Hu Z; Wang L; Xie XQ
AAPS J; 2018 Mar; 20(3):58. PubMed ID: 29603063
[TBL] [Abstract][Full Text] [Related]
24. Big Data and Artificial Intelligence Modeling for Drug Discovery.
Zhu H
Annu Rev Pharmacol Toxicol; 2020 Jan; 60():573-589. PubMed ID: 31518513
[TBL] [Abstract][Full Text] [Related]
25. Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development.
Sarkar C; Das B; Rawat VS; Wahlang JB; Nongpiur A; Tiewsoh I; Lyngdoh NM; Das D; Bidarolli M; Sony HT
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768346
[TBL] [Abstract][Full Text] [Related]
26. Artificial Intelligence (AI) in Drugs and Pharmaceuticals.
Sahu A; Mishra J; Kushwaha N
Comb Chem High Throughput Screen; 2022; 25(11):1818-1837. PubMed ID: 34875986
[TBL] [Abstract][Full Text] [Related]
27. Big Techs and startups in pharmaceutical R&D - A 2020 perspective on artificial intelligence.
Schuhmacher A; Gatto A; Kuss M; Gassmann O; Hinder M
Drug Discov Today; 2021 Oct; 26(10):2226-2231. PubMed ID: 33965571
[TBL] [Abstract][Full Text] [Related]
28. Opportunities and challenges in application of artificial intelligence in pharmacology.
Kumar M; Nguyen TPN; Kaur J; Singh TG; Soni D; Singh R; Kumar P
Pharmacol Rep; 2023 Feb; 75(1):3-18. PubMed ID: 36624355
[TBL] [Abstract][Full Text] [Related]
29. The role and future prospects of artificial intelligence algorithms in peptide drug development.
Chen Z; Wang R; Guo J; Wang X
Biomed Pharmacother; 2024 Jun; 175():116709. PubMed ID: 38713945
[TBL] [Abstract][Full Text] [Related]
30. Machine learning approaches and their applications in drug discovery and design.
Priya S; Tripathi G; Singh DB; Jain P; Kumar A
Chem Biol Drug Des; 2022 Jul; 100(1):136-153. PubMed ID: 35426249
[TBL] [Abstract][Full Text] [Related]
31. Artificial intelligence: Machine learning approach for screening large database and drug discovery.
Parvatikar PP; Patil S; Khaparkhuntikar K; Patil S; Singh PK; Sahana R; Kulkarni RV; Raghu AV
Antiviral Res; 2023 Dec; 220():105740. PubMed ID: 37935248
[TBL] [Abstract][Full Text] [Related]
32. Applications of artificial intelligence (AI) in ovarian cancer, pancreatic cancer, and image biomarker discovery.
Mikdadi D; O'Connell KA; Meacham PJ; Dugan MA; Ojiere MO; Carlson TB; Klenk JA
Cancer Biomark; 2022; 33(2):173-184. PubMed ID: 35213360
[TBL] [Abstract][Full Text] [Related]
33. Application of Artificial Intelligence and Machine Learning in Drug Discovery.
Gupta RR
Methods Mol Biol; 2022; 2390():113-124. PubMed ID: 34731466
[TBL] [Abstract][Full Text] [Related]
34. Closed-loop discovery platform integration is needed for artificial intelligence to make an impact in drug discovery.
Saikin SK; Kreisbeck C; Sheberla D; Becker JS; A AG
Expert Opin Drug Discov; 2019 Jan; 14(1):1-4. PubMed ID: 30488727
[No Abstract] [Full Text] [Related]
35. Artificial intelligence and cheminformatics tools: a contribution to the drug development and chemical science.
Saifi I; Bhat BA; Hamdani SS; Bhat UY; Lobato-Tapia CA; Mir MA; Dar TUH; Ganie SA
J Biomol Struct Dyn; 2024 Aug; 42(12):6523-6541. PubMed ID: 37434311
[TBL] [Abstract][Full Text] [Related]
36. Artificial intelligence in drug discovery: recent advances and future perspectives.
Jiménez-Luna J; Grisoni F; Weskamp N; Schneider G
Expert Opin Drug Discov; 2021 Sep; 16(9):949-959. PubMed ID: 33779453
[No Abstract] [Full Text] [Related]
37. Artificial Intelligence, Machine Learning, and Deep Learning in Real-Life Drug Design Cases.
Muller C; Rabal O; Diaz Gonzalez C
Methods Mol Biol; 2022; 2390():383-407. PubMed ID: 34731478
[TBL] [Abstract][Full Text] [Related]
38. Cheminformatics in Drug Discovery, an Industrial Perspective.
Chen H; Kogej T; Engkvist O
Mol Inform; 2018 Sep; 37(9-10):e1800041. PubMed ID: 29774657
[TBL] [Abstract][Full Text] [Related]
39. Enhancing preclinical drug discovery with artificial intelligence.
Vijayan RSK; Kihlberg J; Cross JB; Poongavanam V
Drug Discov Today; 2022 Apr; 27(4):967-984. PubMed ID: 34838731
[TBL] [Abstract][Full Text] [Related]
40. Artificial intelligence in liver cancers: Decoding the impact of machine learning models in clinical diagnosis of primary liver cancers and liver cancer metastases.
Bakrania A; Joshi N; Zhao X; Zheng G; Bhat M
Pharmacol Res; 2023 Mar; 189():106706. PubMed ID: 36813095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
